TIAA CREF Investment Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $2.5M | Sell |
263,171
-29,478
| -10% | -$280K | ﹤0.01% | 1880 |
|
|
2018
Q4 | $2.59M | Sell |
292,649
-3,629
| -1% | -$32.1K | ﹤0.01% | 1805 |
|
|
2018
Q3 | $3.33M | Sell |
296,278
-358,892
| -55% | -$4.04M | ﹤0.01% | 1852 |
|
|
2018
Q2 | $8.39M | Buy |
655,170
+162,653
| +33% | +$2.08M | 0.01% | 1265 |
|
|
2018
Q1 | $8.32M | Buy |
492,517
+170,591
| +53% | +$2.88M | 0.01% | 1229 |
|
|
2017
Q4 | $2.58M | Buy |
321,926
+63,135
| +24% | +$505K | ﹤0.01% | 1994 |
|
|
2017
Q3 | $2.01M | Buy |
258,791
+79,552
| +44% | +$617K | ﹤0.01% | 2165 |
|
|
2017
Q2 | $1.32M | Buy |
179,239
+35,599
| +25% | +$262K | ﹤0.01% | 2413 |
|
|
2017
Q1 | $1.07M | Sell |
143,640
-6,245
| -4% | -$46.5K | ﹤0.01% | 2480 |
|
|
2016
Q4 | $1.04M | Sell |
149,885
-4,095
| -3% | -$28.5K | ﹤0.01% | 2505 |
|
|
2016
Q3 | $1.27K | Buy |
153,980
+7,026
| +5% | +$58 | ﹤0.01% | 2414 |
|
|
2016
Q2 | $1.19M | Sell |
146,954
-69
| -0% | -$559 | ﹤0.01% | 2420 |
|
|
2016
Q1 | $747K | Hold |
147,023
| – | – | ﹤0.01% | 2623 |
|
|
2015
Q4 | $1.14M | Sell |
147,023
-7,494
| -5% | -$57.9K | ﹤0.01% | 2507 |
|
|
2015
Q3 | $890K | Buy |
154,517
+21,561
| +16% | +$124K | ﹤0.01% | 2632 |
|
|
2015
Q2 | $1.22M | Buy |
+132,956
| New | +$1.22M | ﹤0.01% | 2606 |
|